The inhibitory effect of tocilizumab on systemic bone loss and tendon inflammation in a juvenile Collagen-Induced arthritis rat model

References

• Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–778. doi:10.1016/S0140-6736(07)60363-8.
   PubMed Web of Science ®Google Scholar
• Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138–2149. doi:10.1016/S0140-6736(11)60244-4.
   PubMed Web of Science ®Google Scholar
• Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112–117. doi:10.1016/j.jbspin.2013.09.003.
   PubMed Web of Science ®Google Scholar
• Giancane G, Consolaro A, Lanni S, Davi S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187–207. doi:10.1007/s40744-016-0040-4.
   PubMed Web of Science ®Google Scholar
• Verazza S, Negro G, Marafon D, Consolaro A, Martini A, Ravelli A. Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2013;31(4):S98–101.
   PubMed Web of Science ®Google Scholar
• Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. Ann Rheum Dis. 2015;74(6):1110–1117. doi:10.1136/annrheumdis-2014-205351.
   PubMed Web of Science ®Google Scholar
• Turnier JL, Brunner HI. Tocilizumab for treating juvenile idiopathic arthritis. Expert Opin Biol Ther. 2016;16(4):559–566. doi:10.1517/14712598.2016.1150997.
   PubMed Web of Science ®Google Scholar
• McDonagh JE. Osteoporosis in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2001;13(5):399–404. doi:10.1097/00002281-200109000-000109.
   PubMed Web of Science ®Google Scholar
• Roth J, Bechtold S, Borte G, Dressler F, Girschick HJ, Borte M. Osteoporosis in juvenile idiopathic arthritis–a practical approach to diagnosis and therapy. Eur J Pediatr. 2007;166(8):775–784. doi:10.1007/s00431-007-0484-1.
   PubMed Web of Science ®Google Scholar
• Brabnikova Maresova K. Secondary osteoporosis in patients with juvenile idiopathic arthritis. J Osteoporos. 2011;2011:569417. doi:10.4061/2011/569417.
   PubMedGoogle Scholar
• Harrison BJ, Hutchinson CE, Adams J, Bruce IN, Herrick AL. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis. 2002;61(11):1007–1011. doi:10.1136/ard.61.11.1007.
   PubMed Web of Science ®Google Scholar
• van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(10):3104–3112. doi:10.1002/art.22117.
   PubMed Web of Science ®Google Scholar
• Javadi S, Kan JH, Orth RC, DeGuzman M. Wrist and ankle MRI of patients with juvenile idiopathic arthritis: identification of unsuspected multicompartmental tenosynovitis and arthritis. AJR Am J Roentgenol. 2014;202(2):413–417. doi:10.2214/AJR.13.10671.
   PubMed Web of Science ®Google Scholar
• Slobodin G, Rimar D, Boulman N, Kaly L, Rozenbaum M, Rosner I, Odeh M. Entheseal involvement in systemic disorders. Clin Rheumatol. 2015;34(12):2001–2010. doi:10.1007/s10067-015-3068-x.
   PubMed Web of Science ®Google Scholar
• Fellas A, Hawke F, Santos D, Coda A. Prevalence, presentation and treatment of lower limb pathologies in juvenile idiopathic arthritis: a narrative review. J Paediatr Child Health. 2017;53(9):836–840. doi:10.1111/jpc.13646.
   PubMed Web of Science ®Google Scholar
• Kehl AS, Corr M, Weisman MH. Review: enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment. Arthritis Rheumatol. 2016;68(2):312–322. doi:10.1002/art.39458.
   PubMed Web of Science ®Google Scholar
• Fang Q, Zhou C, Nandakumar KS. Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators Inflamm. 2020;2020:3830212. doi:10.1155/2020/3830212.
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. doi:10.1371/journal.pbio.1000412.
   PubMed Web of Science ®Google Scholar
• Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD. Collagen-induced arthritis. Curr Protoc Immunol. 2010;5:1–25. Chapter 15:Unit 15. doi:10.1002/0471142735.im1505s89.
   Google Scholar
• Bilasy SE, Essawy SS, Mandour MF, Ali EA, Zaitone SA. Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis. Pharmacol Rep. 2015;67(1):102–114. doi:10.1016/j.pharep.2014.08.009.
   PubMed Web of Science ®Google Scholar
• Taskin MI, Gungor AC, Adali E, Yay A, Onder GO, Inceboz U. A humanized anti-interleukin 6 receptor monoclonal antibody, tocilizumab, for the treatment of endometriosis in a rat model. Reprod Sci. 2016;23(5):662–669. doi:10.1177/1933719115612134.
   PubMed Web of Science ®Google Scholar
• Khalifa AK, Diab SA, Hashem GM, Alalkamy EF, Yacoub MF. New promising avenue for the simvastatin combination with residronate, strontium ranelate and raloxifene in experimentally-induced osteoporosis. Egypt Rheumatol. 2020;42(1):63–69. doi:10.1016/j.ejr.2019.07.005.
   Web of Science ®Google Scholar
• Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006;14(1):13–29. doi:10.1016/j.joca.2005.07.014.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang W, Liu Z, Zhu T, Shen W, Ran J, Tang Q, Gong X, Backman LJ, Chen X, Chen X, Wen F, Ouyang H. Characterization and comparison of post-natal rat Achilles tendon-derived stem cells at different development stages. Sci Rep. 2016;6(1):22946. doi:10.1038/srep22946.
   PubMed Web of Science ®Google Scholar
• Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269–1275. doi:10.1038/nprot.2007.173.
   PubMed Web of Science ®Google Scholar
• Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1(4):377–385.
   PubMedGoogle Scholar
• Andreollo NA, Santos EF, Araujo MR, Lopes LR. Rat’s age versus human’s age: what is the relationship? Arq Bras Cir Dig. 2012;25(1):49–51. doi:10.1590/s0102-6720201200010001.
   PubMedGoogle Scholar
• Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013;4(6):624–630.
   PubMedGoogle Scholar
• Akioka S. Interleukin-6 in juvenile idiopathic arthritis. Mod Rheumatol. 2019;29(2):275–286. doi:10.1080/14397595.2019.1574697.
   PubMed Web of Science ®Google Scholar
• Palmqvist P, Persson E, Conaway HH, Lerner UH. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol. 2002;169(6):3353–3362. doi:10.4049/jimmunol.169.6.3353.
   PubMed Web of Science ®Google Scholar
• Wong PK, Quinn JM, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum. 2006;54(1):158–168. doi:10.1002/art.21537.
   PubMed Web of Science ®Google Scholar
• Bellido T, Borba VZ, Roberson P, Manolagas SC. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology. 1997;138(9):3666–3676. doi:10.1210/endo.138.9.5364.
   PubMed Web of Science ®Google Scholar
• Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE. LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone. J Bone Miner Res. 1998;13(2):175–184. doi:10.1359/jbmr.1998.13.2.175.
   PubMed Web of Science ®Google Scholar
• Taguchi Y, Yamamoto M, Yamate T, Lin SC, Mocharla H, DeTogni P, Nakayama N, Boyce BF, Abe E, Manolagas SC. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Proc Assoc Am Physicians. 1998;110(6):559–574.
   PubMedGoogle Scholar
• Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994;13(5):1189–1196. doi:10.1002/j.1460-2075.1994.tb06368.x.
   PubMed Web of Science ®Google Scholar
• Abdel-Maged AE, Gad AM, Abdel-Aziz AK, Aboulwafa MM, Azab SS. Comparative study of anti-VEGF ranibizumab and interleukin-6 receptor antagonist tocilizumab in adjuvant-induced arthritis. Toxicol Appl Pharmacol. 2018;356:65–75. doi:10.1016/j.taap.2018.07.014.
   PubMed Web of Science ®Google Scholar
• Barbe MF, Elliott MB, Abdelmagid SM, Amin M, Popoff SN, Safadi FF, Barr AE. Serum and tissue cytokines and chemokines increase with repetitive upper extremity tasks. J Orthop Res. 2008;26(10):1320–1326. doi:10.1002/jor.20674.
   PubMed Web of Science ®Google Scholar
• Barbe MF, Gallagher S, Massicotte VS, Tytell M, Popoff SN, Barr-Gillespie AE. The interaction of force and repetition on musculoskeletal and neural tissue responses and sensorimotor behavior in a rat model of work-related musculoskeletal disorders. BMC Musculoskelet Disord. 2013;14(1):303. doi:10.1186/1471-2474-14-303.
   PubMed Web of Science ®Google Scholar
• Helrigle C, de Carvalho P, Casalechi HL, Leal-Junior EC, Fernandes GH, Helrigel PA, Rabelo RL, Aleixo-Junior I, Aimbire F, Albertini R. Effects of low-intensity non-coherent light therapy on the inflammatory process in the calcaneal tendon of ovariectomized rats. Lasers Med Sci. 2016;31(1):33–40. doi:10.1007/s10103-015-1821-7.
   PubMed Web of Science ®Google Scholar
• Skutek M, van Griensven M, Zeichen J, Brauer N, Bosch U. Cyclic mechanical stretching enhances secretion of Interleukin 6 in human tendon fibroblasts. Knee Surg Sports Traumatol Arthrosc. 2001;9(5):322–326. doi:10.1007/s001670100217.
   PubMed Web of Science ®Google Scholar
• Nakama K, Gotoh M, Yamada T, Mitsui Y, Yasukawa H, Imaizumi T, Higuchi F, Nagata K. Interleukin-6-induced activation of signal transducer and activator of transcription-3 in ruptured rotator cuff tendon. J Int Med Res. 2006;34(6):624–631. doi:10.1177/147323000603400607.
   PubMed Web of Science ®Google Scholar
• Legerlotz K, Jones ER, Screen HR, Riley GP. Increased expression of IL-6 family members in tendon pathology. Rheumatology (Oxford). 2012;51(7):1161–1165. doi:10.1093/rheumatology/kes002.
   PubMed Web of Science ®Google Scholar
• Lin TW, Cardenas L, Glaser DL, Soslowsky LJ. Tendon healing in interleukin-4 and interleukin-6 knockout mice. J Biomech. 2006;39(1):61–69. doi:10.1016/j.jbiomech.2004.11.009.
   PubMed Web of Science ®Google Scholar
• Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135(2):112–124. doi:10.1111/j.1365-2567.2011.03522.x.
   PubMed Web of Science ®Google Scholar
• Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, Gorman DM, Bowman EP, MacClanahan TK, Yearly JH, Eberl G, Buckley CD, Kastelein RA, Pierce RH, LaFace DM, Cua DJ. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18(7):1069–1076. doi:10.1038/nm.2817.
   PubMed Web of Science ®Google Scholar
• Araujo EG, Schett G. Enthesitis in psoriatic arthritis (Part 1): pathophysiology. Rheumatology (Oxford). 2020;59(Supplement_1):i10–i4. doi:10.1093/rheumatology/keaa039.
   PubMedGoogle Scholar
• Poutoglidou F, Pourzitaki C, Manthou ME, Samoladas E, Malliou F, Saitis A, Kouvelas D. Effects of long-term methotrexate, infliximab and tocilizumab administration on bone microarchitecture and tendon morphology in healthy Wistar rats. Cureus. 2021;13(4):e14696. doi:10.7759/cureus.14696.
   PubMed Web of Science ®Google Scholar